| BST-E-309-C025 | ISG15 E1 (human) (rec.) | 25 ug |
| BST-E-310-C050 | Aos1p/Uba2p (rec.) (GST) | 50 ug |
| BST-E-311-C025 | Aos1p/Uba2p (rec.) | 25 ug |
| BST-E-312-C050 | APPBP1/Uba3 (human) (rec.) (GST) | 50 ug |
| BST-E-313-C025 | APPBP1/Uba3 (human) (rec.) | 25 ug |
| BST-E-315-C025 | SUMO Activating Enzyme (human) (rec.) | 25 ug |
| BST-E-317-C025 | Apg7L (human) (rec.) (His) | 25 ug |
| BST-E-320-C010 | Isopeptidase T (rabbit) | 10 ug |
| BST-E-320-C025 | Isopeptidase T (rabbit) | 25 ug |
| BST-E-322-C025 | Isopeptidase T (human) (rec.) | 25 ug |
| BST-E-324-C025 | Isopeptidase T (human) (rec.) (short form) | 25 ug |
| BST-E-325-C025 | Ubiquitin C-terminal Hydrolase Isozyme L3 (human) (rec.) | 25 ug |
| BST-E-330-C010 | Ubiquitin C-terminal Hydrolase Isozyme L3 (rabbit) | 10 ug |
| BST-E-330-C025 | Ubiquitin C-terminal Hydrolase Isozyme L3 (rabbit) | 25 ug |
| BST-E-335-C025 | Ubiquitin C-terminal Hydrolase Isozyme L1 (mouse) (rec.) (His) | 25 ug |
| BST-E-340-C025 | Ubiquitin C-terminal Hydrolase Isozyme L1 (human) (rec.) | 25 ug |
| BST-E-342-C025 | USP14 (human) (rec.) | 25 ug |
| BST-E-350-C025 | Proteasome 20S (rabbit) | 25 ug |
| BST-E-350-C050 | Proteasome 20S (rabbit) | 50 ug |
| BST-E-360-C050 | Proteasome 20S (human) | 50 ug |
| BST-E-370-C025 | Immunoproteasome 20S (human) | 25 ug |
| BST-E-375-C050 | Immunoproteasome 20S (rat) | 50 ug |
| BST-E-380-C010 | PA28 Activator (human) (rec.) | 10 ug |
| BST-E-380-C025 | PA28 Activator (human) (rec.) | 25 ug |
| BST-E-400-C025 | Apg4b (human) (rec.) (His) | 25 ug |
| BST-E-700-C050 | SENP1 (Catalytic Domain) (human) (rec.) (His) | 50 ug |
| BST-E-710-C050 | SENP2 (Catalytic Domain) (human) (rec.) (His) | 50 ug |
| BST-E-800-C050 | NEDP1 (human) (rec.) (His) | 50 ug |
| BST-F-340-C400 | Ubiquitin Conjugating Enzyme Fractions (mammalian) | 400 ug |
| BST-F-360-M005 | Fraction II [FII] (rabbit reticulocyte) | 5 mg |
| BST-F-360-MC25 | Fraction II [FII] (rabbit reticulocyte) | 2.5 mg |
| BST-F-365-R200 | Proteasome Fraction 26S (mammalian) | 200 ul |
| BST-F-370-M001 | Fraction II [FII] (Hela) | 1 mg |
| BST-F-370-MC25 | Fraction II [FII] (Hela) | 2.5 mg |
| BST-F-372-MC25 | S-100 Fraction (Hela) | 2.5 mg |
| BST-F-375-M001 | Fraction I [FI] (Hela) | 1 mg |
| BST-F-375-MC25 | Fraction I [FI] (Hela) | 2.5 mg |
| BST-I-100-C200 | clasto-Lactacystin beta-lactone (synthetic) | 200 ug |
| BST-I-102-M001 | clasto-Lactacystin beta-lactone (synthetic) | 1 mg |
| BST-I-110-C200 | Epoxomicin | 200 ug |
| BST-I-112-M001 | Epoxomicin | 1 mg |
| BST-I-114-C100 | Lactacystin (synthetic) | 100 ug |
| BST-I-115-C500 | Lactacystin (synthetic) | 500 ug |
| BST-I-116-M001 | Lactacystin (synthetic) | 1 mg |
| BST-I-120-C200 | Proteasome Inhibitor III | 200 ug |
| BST-I-122-M001 | Proteasome Inhibitor III | 1 mg |
| BST-I-130-M001 | MG-132 | 1 mg |
| BST-I-130-M005 | MG-132 | 5 mg |
| BST-I-135-M005 | Z-Leu-Leu-Nva-CHO | 5 mg |
| BST-I-140-M005 | Proteasome Inhibitor I (Aldehyde) | 5 mg |
| BST-I-150-M001 | Proteasome Inhibitor II (Aldehyde) | 1 mg |
| BST-I-160-M005 | Calpain Inhibitor I | 5 mg |
| BST-I-170-M005 | Calpain Inhibitor II | 5 mg |
| BST-I-200-M010 | BAY 11-7082 | 10 mg |
| BST-I-201-M010 | BAY 11-7085 | 10 mg |
| BST-I-210-C500 | Panepoxydone | 500 ug |
| BST-I-220-R050 | NBD Peptide / NF-kappaB Blocker (cell permeable) | 50 ul |
| BST-K-600-KI01 | ISG15 Conjugation Initiation Kit | 1 Kit |
| BST-K-700-KI01 | SUMO Proteins (1, 2 and 3) Kit (human) (rec.) | 1 Kit |
| BST-K-705-KI01 | SUMO Proteins (1, 2 and 3) Kit (human) (rec.) (His) | 1 Kit |
| BST-K-710-KI01 | SUMO-1 Conjugation Kit (human) (rec.) | 1 Kit |
| BST-K-715-KI01 | SUMO-2 Conjugation Kit (human) (rec.) | 1 Kit |
| BST-K-720-KI01 | SUMO-3 Conjugation Kit (human) (rec.) | 1 Kit |
| BST-K-800-KI01 | NEDD8 Conjugation Initiation Kit | 1 Kit |
| BST-K-900-KI01 | Proteasome 20S Assay Kit | 1 Kit |
| BST-K-910-KI01 | S-100 (Hela) Degradation Kit | 1 Kit |
| BST-K-915-KI01 | S-100 (Hela) Conjugation Kit | 1 Kit |
| BST-K-920-KI01 | Fraction II [FII] (Hela) Degradation Kit | 1 Kit |
| BST-K-925-KI01 | Fraction II [FII] (rabbit reticulocyte) Degradation Kit | 1 Kit |
| BST-K-930-KI01 | Fraction II [FII] (Hela) Conjugation Kit | 1 Kit |
| BST-K-935-KI01 | Fraction II [FII] (rabbit reticulocyte) Conjugation Kit | 1 Kit |
| BST-K-950-KI01 | Proteasome 26S Degradation Kit | 1 Kit |
| BST-K-960-KI01 | Ubiquitin Conjugation Kit | 1 Kit |
| BST-K-980-KI01 | UbcH (rec.) Enzymes Set | 1 Kit |
| BST-K-985-KI01 | UbcH (C-S active site mutant) (rec.) Enzymes Set | 1 Kit |
| BST-K-995-KI01 | Ubiquitin Conjugation Initiation Kit | 1 Kit |
| BST-P-100-C020 | NF-kappaB (p50) (human) (rec.) (His) | 20 ug |
| BST-S-220-M005 | Proteasome Substrate I (Fluorogenic) | 5 mg |
| BST-S-230-M005 | Proteasome Substrate II (Fluorogenic) | 5 mg |
| BST-S-260-M005 | Suc-Leu-Tyr-AMC (Fluorogenic) | 5 mg |
| BST-S-280-M005 | Proteasome Substrate III (Fluorogenic) | 5 mg |
| BST-SP-100-C050 | Biotin-Lysozyme Conjugation Substrate | 50 ug |
| BST-SP-200-C050 | E2-25K SUMO Conjugation Substrate (human) (rec.) | 50 ug |
| BST-SP-205-C025 | E2-25K SUMO Conjugation Substrate (human) (rec.) (Biotin) | 25 ug |
| BST-SP-300-C020 | SUMO Conjugation Peptide Substrate (Biotin) | 20 ug |
| BST-SP-305-C020 | SUMO Conjugation Peptide Substrate (Biotin) (Negative Control) | 20 ug |
| BST-U-100H-M010 | Ubiquitin (human) (rec.) | 10 mg |
| BST-U-100-M010 | Ubiquitin (mammalian) | 10 mg |
| BST-U-110-M001 | Ubiquitin (human) (rec.) (HA) | 1 mg |
| BST-U-115-M001 | Ubiquitin (human) (rec.) (Myc) | 1 mg |
| BST-U-120-M001 | Ubiquitin (human) (rec.) (FLAG) | 1 mg |
| BST-U-201-C050 | Ubiquitin Aldehyde (human) (rec.) | 50 ug |
| BST-U-202-C025 | Ubiquitin Vinyl Sulfone (human) (rec.) | 25 ug |
| BST-U-400-L001 | Ubiquitin (human) (rec.) (Agarose) | 1 ml |
| BST-U-405-LC05 | Ubiquitin (human) (rec.) (Agarose) | 0.5 ml |
| BST-U-501-M005 | Ubiquitin (human) (rec.) (Methylated) | 5 mg |
| BST-U-502-M001 | Ubiquitin (human) (rec.) (Methylated) | 1 mg |
| BST-U-520-M001 | Ubiquitin (K48R mutant) (human) (rec.) (His) | 1 mg |
| BST-U-530-M002 | Ubiquitin (human) (rec.) (His) | 2 mg |
| BST-U-540-M001 | Ubiquitin (human) (rec.) (GST) | 1 mg |
| BST-U-550-C050 | Ubiquitin (human) (rec.) (AMC) | 50 ug |
| BST-U-560-C050 | Ubiquitin (human) (rec.) (Biotin, NT) (His) | 50 ug |
| BST-U-570-C100 | Ubiquitin (human) (rec.) (Biotin) | 100 ug |
| BST-U-580-C050 | Ubiquitin (human) (rec.) (Fluorescein, NT) (His) | 50 ug |
| BST-U-590-C100 | Ubiquitin (human) (rec.) (Fluorescein) | 100 ug |
| BST-U-600-C050 | Ubiquitin (human) (rec.) (Rhodamine, NT) | 50 ug |
| BST-UB-560-C050 | Ubiquitin (human) (rec.) (Biotin, NT) | 50 ug |
| BST-UB-HK480-C050 | Ubiquitin (mutant, K48 only) (human) (rec.) (Biotin, NT) (His) | 50 ug |
| BST-UB-HK630-C050 | Ubiquitin (mutant, K63 only) (human) (rec.) (Biotin, NT) (His) | 50 ug |
| BST-UB-K480-C050 | Ubiquitin (mutant, K48 only) (human) (rec.) (Biotin, NT) | 50 ug |
| BST-UB-K630-C050 | Ubiquitin (mutant, K63 only) (human) (rec.) (Biotin, NT) | 50 ug |
| BST-UB-NOK-C050 | Ubiquitin (mutant, no lysines) (human) (rec.) (Biotin, NT) | 50 ug |
| BST-UC-200-C100 | Di-ubiquitin WT Chains (Ub2, K48-linked) (human) (rec.) | 100 ug |
| BST-UC-210-C025 | Tetra-ubiquitin WT Chains (Ub4, K48-linked) (human) (rec.) | 25 ug |
| BST-UC-215-C100 | Tri-ubiquitin WT Chains (Ub3, K48-linked) (human) (rec.) | 100 ug |
| BST-UC-216-C025 | Penta-ubiquitin WT Chains (Ub5, K48-linked) (human) (rec.) | 25 ug |
| BST-UC-217-C025 | Hexa-ubiquitin WT Chains (Ub6, K48-linked) (human) (rec.) | 25 ug |
| BST-UC-220-C100 | Polyubiquitin WT Chains (Ub3-7, K48-linked) (human) (rec.) | 100 ug |
| BST-UC-230-C100 | Polyubiquitin WT Chains (Ub2-7, K48-linked) (human) (rec.) | 100 ug |
| BST-UC-240-C100 | Polyubiquitin WT Chains (Ub1-7, K48-linked) (human) (rec.) | 100 ug |
| BST-UC-300-C050 | Di-ubiquitin WT Chains (Ub2, K63-linked) (human) (rec.) | 50 ug |
